Pfizer Promoting Tiered Drug Coverage Policy For Middle-Income Nations
Pfizer is advocating a new U.S. trade stance toward setting parameters around foreign governments' drug reimbursement policies in middle-income nations
You may also be interested in...
A Senate bill would block bank loans to countries that fail to implement intellectual property protections mandated by the U.S. government
If not reversed by the Biden Administration, demo program that puts plans at increased risk in catastrophic phase would also enhance negotiating leverage for drugs in the protected classes.
Tactic aims to allow incoming Administration to scrutinize so-called ‘midnight rules’ issued in the final days of the Trump Administration before they take effect. Regulators may also solicit stakeholder comments on delayed rules.